BP

BVF Partners

North America, California, United States, San Francisco

Description

BVF Partners invests in small-cap biotechnology companies.

Investor Profile

BVF Partners has made 23 investments, with 7 in the past 12 months and 39% as lead.

Stage Focus

  • Post Ipo Equity (48%)
  • Series A (17%)
  • Series B (13%)
  • Series C (9%)
  • Private Equity (4%)
  • Convertible Note (4%)
  • Series F (4%)

Country Focus

  • United States (96%)
  • United Kingdom (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Medical
  • Oncology
  • Biopharma
  • Clinical Trials
  • Medical Device
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BVF Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 5
Blue Owl
North America, New York, United States, New York
Co-Investments: 3
Avidity Partners
North America, Texas, United States, Dallas
Co-Investments: 3
RTW Investments
North America, New York, United States, New York
Co-Investments: 3
TCG Crossover
North America, California, United States, Palo Alto
Co-Investments: 4
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 7
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 4
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 3
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 4
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 3

What are some of recent deals done by BVF Partners?

Tenax Therapeutics

Chapel Hill, North Carolina, United States

Tenax Therapeutics focuses on identifying and developing treatments that address cardiovascular and pulmonary diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityAug 6, 2024
Amount Raised: $100,000,000
Ambrosia Biosciences

Boulder, Colorado, United States

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

BiopharmaBiotechnologyHealth Care
Series AAug 6, 2024
Amount Raised: $16,000,000
Autobahn Therapeutics

San Diego, California, United States

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

BiotechnologyHealth CareLife ScienceTherapeutics
Series CJul 24, 2024
Amount Raised: $100,000,000
Third Arc Bio

Boston, Massachusetts, United States

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

BiotechnologyHealth CareLife ScienceMedicalOncology
Series AJul 23, 2024
Amount Raised: $165,000,000
Celcuity

Hamel, Minnesota, United States

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo EquityMay 30, 2024
Amount Raised: $60,000,000
Pheon Therapeutics

London, England, United Kingdom

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

BiotechnologyLife ScienceMedicalTherapeutics
Series BMay 21, 2024
Amount Raised: $120,000,000
Cullinan Therapeutics

Cambridge, Massachusetts, United States

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

BiopharmaBiotechnologyMedical DeviceOncology
Post Ipo EquityApr 16, 2024
Amount Raised: $280,000,000
Diagonal Therapeutics

Cambridge, Massachusetts, United States

Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies.

BiopharmaBiotechnologyMedical
Series AApr 3, 2024
Amount Raised: $128,000,000
Molecular Templates

Austin, Texas, United States

Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityMar 28, 2024
Amount Raised: $9,500,000
Avalo Therapeutics

Rockville, Maryland, United States

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

BiotechnologyTherapeutics
Post Ipo EquityMar 27, 2024
Amount Raised: $115,600,000